We are focused on democratizing genetic testing and revolutionizing the customer experience.
We have a clear mission at mindwerks: Unlocking the promise of personalized medicine. We have assembled a team of technology experts and industry leaders to challenge established thinking, inspire innovation, and drive change. Together, we are reshaping the future of genetic testing.
Dirk van den Boom
Dirk has nearly 20 years of experience and is a recognized leader in the development and commercialization of reproductive health diagnostics. Most recently, Dirk served as President, CEO and director of Sequenom, a clinical diagnostic company, prior to its acquisition by LabCorp. Dirk has co-authored 95 articles published in peer-reviewed journals and is inventor on more than 80 patents and patent applications. He received his Ph.D. in Biochemistry and Molecular Biology from the University of Hamburg.
Jim has over 15 years of experience in the life sciences industry and specializes in strategy formulation, technology innovation, and product development. Prior to mindwerks, he led the strategy and corporate development functions at Sequenom. Jim earned his MBA from the Massachusetts Institute of Technology (MIT) Sloan School of Management and his BSc. from the University of California at Davis.
mindwerks is combining world class expertise in nucleic acid detection, circulating cell free DNA, molecular biology, and clinical insight to develop novel, best-in-class biochemistries and assays formats.
The technologies we are developing have the potential to address the needs of many patients across a variety of fields. While our initial focus will be on reproductive health, these technologies may be applied to pediatric health, neurology, immunology and oncology.
In order to increase the accessibility of genetic testing we believe that cost effective approaches are necessary along with new biochemistries and assay formats.
9191 Towne Centre Dr., Suite 575
San Diego, California 92122
Copyright mindwerks bio